0       0

29th Annual North American Cystic Fibrosis Conference


*** W20: PT & RT: Aerosol Therapy: How Are We Delivering Inhaled Medications in 2015: Past, Present & Future


Oct 9, 2015 2:00pm ‐ Oct 9, 2015 3:45pm

Standard: $49.99

Description

Physicians must choose from an ever-expanding arsenal of therapies intended to maintain lung health for patients with CF. There has been extensive research not only in the development of these medications, but also in their improved delivery. This workshop will focus on the safety & efficacy, as well as patient adherence in the evolving era of aerosolized medications.

Educational Objectives:

  1. Describe strategies for choosing nebulizers for the inpatient setting & minimizing immediate side effects of aerosolized therapies.
  2. Discuss the long-term safety & efficacy of Tobramycin Inhalation Powder (TIPtm) & adherence to TIP(tm) versus Tobramycin Inhalation Solution.
  3. Identify barriers to medication adherence & discuss the changes to adherence after using ivacaftor. 
*** This session was streamed live during the 2015 NACFC. To watch free archived versions of the live streamed sessions, register here: https://arc.nacfconference.org/cff/live/14 

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content